Abstract: The invention provides for a RANKL-specific antagonistic agent recognizing human platelet-expressed receptor activator of nuclear factor kappa-B ligand (pRANKL), for use in treating a cancer patient to prevent or reduce premetastatic lesions in blood.

Abstract: The invention provides for a RANKL-specific antagonistic agent recognizing human platelet-expressed receptor activator of nuclear factor kappa-B ligand (pRANKL), for use in treating a cancer patient to prevent or reduce premetastatic lesions in blood.

Abstract: The invention relates to a hydrocarbon mixture that contains at least two hydrocarbons that are different from each other, the number of carbons thereof differing by more than one, wherein said two hydrocarbons that differ from each other make up at least 60% by weight, preferably at least 70% by weight of the total of the hydrocarbons. The invention also relates to the use of said hydrocarbon mixtures and to cosmetic and/or pharmaceutical preparations containing said hydrocarbon mixtures.

Abstract: A RANKL-inhibitor for use in the treatment of a patient suffering from chemotherapy resistant cancer, which patient has a diagnosis of cancer that is unresponsive to treatment with a first chemotherapeutic agent, wherein said cancer is not a solid tumor or metastasis in the bone, and said patient is administered a second chemotherapeutic agent in combination with said RANKL-inhibitor.

Abstract: The invention relates to a hydrocarbon mixture that contains at least two hydrocarbons that are different from each other, the number of carbons thereof differing by more than one, wherein said two hydrocarbons that differ from each other make up at least 60% by weight, preferably at least 70% by weight of the total of the hydrocarbons. The invention also relates to the use of said hydrocarbon mixtures and to cosmetic and/or pharmaceutical preparations containing said hydrocarbon mixtures.

Abstract: The invention relates to esters of general formula (I) R1—C(?O)—O—R2, wherein (1) R1 represents a linear alkyl radical having 7 to 9 carbon atoms and R2 represents a linear alkyl radical having 9 to 10 carbon atoms or (2) R1 is a linear alk radical having 8 to 9 carbon atoms and R2 is a linear alkyl radical having 8 carbon atoms, or (3) R1 is a linear alkyl radical having 7 to 9 carbon atoms and R2 is a linear alkyl radical having 7 carbon atoms, or (4) R1 is an alkyl radical having 7 or 8 carbon atoms and R2 is an alkyl radical having 9 carbon atoms where, if R1 is a linear alkyl radical, R2 is a branched alkyl radical, or, if R1 is a branched alkyl radical, R2 is a linear alkyl radical or (5) R1 represents an alkyl radical having 8 carbon atoms and R2 is an alkyl radical having 8 carbon atoms, where, if R1 is a linear alkyl radical, R2 is a branched alkyl radical, or, if R1 is a branched alkyl radical, R2 is a linear alkyl radical, or n-octyl isooctanoate, n-decyl isooctanoate, n-decyl isononanoate, isonony

Abstract: The invention relates to hydrocarbon mixtures containing the 14C isotope, use thereof and cosmetic and/or pharmaceutical preparations comprising hydrocarbon mixtures containing the 14C isotope.

Abstract: The invention relates to esters of general formula (I) R1—C(?O)—O—R2, wherein (1) R1 represents a linear alkyl radical having 7 to 9 carbon atoms and R2 represents a linear alkyl radical having 9 to 10 carbon atoms or (2) R1 is a linear alkyl radical having 8 to 9 carbon atoms and R2 is a linear alkyl radical having 8 carbon atoms, or (3) R1 is a linear alkyl radical having 7 to 9 carbon atoms and R2 is a linear alkyl radical having 7 carbon atoms, or (4) R1 is an alkyl radical having 7 or 8 carbon atoms and R2 is an alkyl radical having 9 carbon atoms where, if R1 is a linear alkyl radical, R2 is a branched alkyl radical, or, if R1 is a branched alkyl radical, R2 is a linear alkyl radical or (5) R1 represents an alkyl radical having 8 carbon atoms and R2 is an alkyl radical having 8 carbon atoms, where, if R1 is a linear alkyl radical, R2 is a branched alkyl radical, or, if R1 is a branched alkyl radical, R2 is a linear alkyl radical, or n-octyl isooctanoate, n-dec I isooctanoate, n-decyl isononanoate, isono

Abstract: The invention relates to a hydrocarbon mixture that contains at least two hydrocarbons that are different from each other, the number of carbons thereof differing by more than one, wherein said two hydrocarbons that differ from each other make up at least 60% by weight, preferably at least 70% by weight of the total of the hydrocarbons. The invention also relates to the use of said hydrocarbon mixtures and to cosmetic and/or pharmaceutical preparations containing said hydrocarbon mixtures.

Abstract: The invention relates to hydrocarbon mixtures containing the 14C isotope, use thereof and cosmetic and/or pharmaceutical preparations comprising hydrocarbon mixtures containing the 14C isotope.